Vtv Therapeutics Inc. · NASDAQ:VTVT
Raymond Debbane reported a 9.99% stake in Vtv Therapeutics Inc. (Schedule 13G)
Event Aug 29, 2025 · Filed Sep 8, 2025
Raymond Debbane reported a 9.99% stake in Vtv Therapeutics Inc., 348,083 shares, as a passive investor on Aug 29, 2025. Filed Sep 8, 2025 (Schedule 13G).
- Stake
- 9.99%
- Shares
- 348,083
- Intent
- Passive
- What changed
- Crossed above 5%
- Filed together
- 8 holders
The filing in full
| Holder | Stake | Shares |
|---|---|---|
| Invus Public Equities, L.P. | 8.80% | 306,313 |
| Invus Public Equities Advisors, LLC | 8.80% | 306,313 |
| Invus Global Management, LLC | 8.80% | 306,313 |
| Siren, L.L.C. | 8.80% | 306,313 |
| Avicenna Life Sci Master Fund LP | 1.30% | 41,770 |
| Avicenna Life Sci Master GP LLC | 1.30% | 41,770 |
| Ulys, L.L.C. | 1.30% | 41,770 |
| Raymond Debbane | 9.99% | 348,083 |
Source
Related
- Vtv Therapeutics Inc.
- Invus Public Equities, L.P.
- Vtv Therapeutics Inc. shareholders
- Schedule 13G/A · Invus Public Equities, L.P. · Nov 12, 2025
- Schedule 13G/A · Millennium Management LLC · Oct 8, 2026
- Schedule 13G/A · Millennium Management LLC · Jul 29, 2026
- Schedule 13G/A · Millennium Management LLC · Apr 16, 2026
- Schedule 13G · Millennium Management LLC · Mar 27, 2026
- Schedule 13D/A · Akkaraju Srinivas · Dec 9, 2025